Statins reduced negative emotional bias in people with depression. The findings suggest statins may provide protection against depression.
Older adults who take statin drugs have a lower risk of developing Parkinson's disease or parkinsonism symptoms later in life compared to those who do not take statins. Researchers speculate this may be because statins have a neuroprotective effect on arteries in the brain.
Adding icosapent ethyl, a triglyceride-lowering medication that is high in the omega 3 fatty acid, eicosapentaenoic acid, in combination with statins helped to reduce stroke risk by 36% in those with cardiovascular disease.
Cholesterol-lowering statins show promise for the treatment of severe coronavirus infections. Statins lowered the death rate and decreased the need for mechanical ventilation in patients hospitalized for severe COVID-19.
Study reveals there is no link between memory decline and statin use in older adults. Additionally, no association was found between statin use and cognitive decline in those with genetic risk factors for dementia.
Lovastatin, a common statin usually prescribed to control cholesterol, corrected learning and memory deficits associated with Fragile X syndrome in rodent models.
The common statin drug Simvastatin reduces brain atrophy and slows the progression of secondary progressive multiple sclerosis (SPMS). The effects appear to be independent of the drug's cholesterol-lowering effects.
Anti-inflammatory medications, such as those commonly prescribed for arthritis, improve depressive symptoms in those with MDD.
A new study reports high cholesterol may contribute to the risk of developing ALS. The findings suggest cholesterol lowering drugs, such as statins, could help to prevent the onsite of the neurodegenerative disease.
A new study reveals statins, biguanides and other drugs that help treat physical conditions may have significant benefits for the treatment of bipolar disorder and schizophrenia.
Researchers report statins could potentially reduce cardiovascular risks in people with Friedreich's ataxia.
Study reveals statins are associated with a reduced risk of Alzheimer's disease, but the reduction of risk varied by race, ethnicity and statin type.
